Clinical applications of flow sequences in cardiac magnetic resonance imaging
DOI:
https://doi.org/10.37615/retic.v7n3a2Keywords:
Cardiac magnetic resonance, Phase contrast sequences, Magnetic resonance flow quantification, 4D flowAbstract
Cardiac magnetic resonance imaging is an excellent technique for cardiac anatomical and functional assessment in all types of clinical contexts. In this article we will review the application of phase contrast sequences, which are sequences that allow the study of cardiac flows, in different clinical scenarios.
Downloads
Metrics
References
Sheth PJ, Danton GH, Siegel Y, et al. Cardiac Physiology for Radiologist: Review of Relevant Physiology for interpretation of Cardiac MR Imaging and CT. Radiographics 2015 35:5, 1335-1351. https://doi.org/doi:10.1148/rg.2015140234 DOI: https://doi.org/10.1148/rg.2015140234
Lotz J, Meier C, Leppert A, et al. Cardiovascular Flow Measurement Phase-Constrat MR imaging: Basic Facts and Implementation. RadioGraphics 2002 22:3, 651-671. https://doi.org/doi:10.1148/radiographics.22.3.g02ma11651 DOI: https://doi.org/10.1148/radiographics.22.3.g02ma11651
Caroff J, Bière L, Trebuchet G, et al. Applications of phase-contrast velocimetry sequences in cardiovascular imaging. Diagnostic and Interventional Imaging. Volume 93, Issue 3,2012, Pages 159-170. https://doi.org/10.1016/j.diii.2012.01.008 DOI: https://doi.org/10.1016/j.diii.2012.01.008
Jacobs K, Hahn L, Horowitz M, et al. Hemodynamic Assessment of Structural Heart Disease Using 4D Flow MRI: How We Do It. AJR Am J Roentgenol. 2021;217(6):1322-1332. https://doi.org/doi:10.2214/AJR.21.25978. DOI: https://doi.org/10.2214/AJR.21.25978
Vahanian A, Beyersdorf F, Praz F et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), European Heart Journal 2022;43(7):561–632. https://doi.org/doi:10.1016/j.rec.2022.05.006 DOI: https://doi.org/10.1093/eurheartj/ehac051
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e35-e71. https://doi.org/doi:10.1161/CIR.0000000000000932 DOI: https://doi.org/10.1161/CIR.0000000000000966
Uretsky S, Argulian E, Narula J,et al. Use of Cardiac Magnetic Resonance Imaging in Assessing Mitral Regurgitation: Current Evidence, Journal of the American College of Cardiology 2017:71(5):547-563. https://doi.org/doi:10.1016/j.jacc.2017.12.009 DOI: https://doi.org/10.1016/j.jacc.2017.12.009
Feneis JF, Kyubwa E, Atianzar K, et al. 4D flow MRI quantification of mitral and tricuspid regurgitation: Reproducibility and consistency relative to conventional MRI. J Magn Reson Imaging. 2018;48(4):1147-1158. https://doi.org/10.1002/jmri.26040 DOI: https://doi.org/10.1002/jmri.26040
Guzzetti E, Racine HP, Tastet L, et al. Accuracy of stroke volume measurement with phase-contrast cardiovascular magnetic resonance in patients with aortic stenosis. J Cardiovasc Magn Reson 23, 124 (2021). https://doi.org/doi:10.1186/s12968-021-00814-4 DOI: https://doi.org/10.1186/s12968-021-00814-4
Chamsi-Pasha MA, Zhan Y, Debs D, et al. CMR in the Evaluation of Diastolic Dysfunction and Phenotyping of HFpEF: Current Role and Future Perspectives, JACC Cardiovascular Imaging 2020 13 (1) 283-296, https://doi.org/doi:10.1016/j.jcmg.2019.02.031 DOI: https://doi.org/10.1016/j.jcmg.2019.02.031
Buechel V, Grosse-Wortmann L, Fratz S, et al. Indications for cardiovascular magnetic resonance in children with congenital and acquired heart disease: an expert consensus paper of the Imaging Working Group of the AEPC and the Cardiovascular Magnetic Resonance Section of the EACVI, European Heart Journal - Cardiovascular Imaging, Volume 16, Issue 3, March 2015, Pages 281–297. https://doi.org/doi:10.1093/ehjci/jeu129 DOI: https://doi.org/10.1093/ehjci/jeu129
Reiter U, Reiter G, Fuchsjäger M. MR phase-contrast imaging in pulmonary hypertension. Br J Radiol. 2016 Jul;89(1063). https://doi.org/doi:10.1259/bjr.20150995 DOI: https://doi.org/10.1259/bjr.20150995
Ntsinjana HN, Hughes ML, Taylor AM. The role of cardiovascular magnetic resonance in pediatric congenital heart disease. J Cardiovasc Magn Reason. 2011;13(1):51. https://doi.org/doi:10.1186/1532-429X-13-51 DOI: https://doi.org/10.1186/1532-429X-13-51
Glatz AC, Rome JJ, Small AJ, et al. Systemic-to-pulmonary collateral flow, as measured by cardiac magnetic resonance imaging, is associated with acute post-Fontan clinical outcomes. Circ Cardiovasc Imaging. 2012;5(2):218-225. https://doi.org/doi:10.1161/CIRCIMAGING.111.966986 DOI: https://doi.org/10.1161/CIRCIMAGING.111.966986
Whitehead KK, Harris MA, Glatz AC, et al. Status of systemic to pulmonary arterial collateral flow after the fontan procedure. Am J Cardiol. 2015;115(12):1739-1745. https://doi.org/doi:10.1016/j.amjcard.2015.03.022 DOI: https://doi.org/10.1016/j.amjcard.2015.03.022
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 María Leticia Liébana Carpio, Almudena Ortiz Garrido, Rocío Rodríguez Ortega
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
RETIC is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license https://creativecommons.org/licenses/by-nc-nd/4.0 which allows sharing, copying and redistribution of the material in any medium or format, under the following terms:
- Attribution: you must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests that the licensor endorses you or your use.
- Non-commercial: you may not use the material for commercial purposes.
- No Derivatives: if you remix, transform or build upon the material, you may not distribute the modified material.
- No Additional Restrictions: you may not apply legal terms or technological measures that legally restrict others from doing anything permitted by the license.